Sufferers were given a transtelephonic monitor for the 18-month follow-up period and were asked to transmit rhythm recordings weekly and any time they had symptoms such as for example palpitations, dizziness, or shortness of breath. Holter-monitor and Electrocardiograms recordings were read by clinicians who have been unaware of the procedure assignments. Transmissions from the transtelephonic monitor were read individually by core laboratory employees who were unaware of the procedure assignments. Study Outcomes The principal study outcome was freedom from any documented bout of atrial fibrillation lasting longer than 30 seconds and occurring following the performance of a single ablation procedure, with or without the use of antiarrhythmic medicines.These findings display that genomic loss of the patient-specific HLA haplotype occurred in vivo after transplantation. To determine the level and the system of the loss of heterozygosity in the patients with relapsed leukemia, we performed microsatellite SNP and mapping arrays of chromosome 6, like the HLA region. In every five patients, the analyses showed loss of heterozygosity involving the short arm of chromosome 6, encompassing the HLA area and causing lack of the patient-specific haplotype . Evaluation of copy-number variations showed no deletions in chromosome 6p, a finding that is good observed karyotype. On the basis of these total results, we concluded that loss of the HLA haplotype was due to obtained partial uniparental disomy of chromosome 6 with cells attained from the patient at the time of analysis.